Published in Hepatitis Weekly, February 6th, 2006
New investors joining the series B round include PAC-LINK Bio Venture Capital, China Investment and Development (CIDC), and Yasuda Enterprise Development. The series B financing was led by Lilly Ventures and also included HealthCare Ventures, Morgenthaler Ventures, Sequel Venture Partners, Medica Venture Partners, Adams Street Partners, Biogen Idec, Inc., Genentech, Inc., Partners Healthcare, and GC&H...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.